Retracted Article: Gemcitabine aggravates miR-199a-5p-mediated breast cancer cell apoptosis by promoting VEGFA downregulation <i>via</i> inactivating the AKT signaling pathway

Dingmei Deng, Xian Ye, Xiyue Wang, Guangning He

DOI: 10.1039/c9ra00016j
Published: 2019
Container: RSC Advances
Publisher: Royal Society of Chemistry (RSC)
Open access: unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1039/c9ra00016j,
  title = {Retracted Article: Gemcitabine aggravates miR-199a-5p-mediated breast cancer cell apoptosis by promoting VEGFA downregulation
                    <i>via</i>
                    inactivating the AKT signaling pathway},
  author = {Dingmei Deng and Xian Ye and Xiyue Wang and Guangning He},
  year = {2019},
  journal = {RSC Advances},
  doi = {10.1039/c9ra00016j},
  url = {https://doi.org/10.1039/c9ra00016j}
}

RIS

TY  - JOUR
TI  - Retracted Article: Gemcitabine aggravates miR-199a-5p-mediated breast cancer cell apoptosis by promoting VEGFA downregulation
                    <i>via</i>
                    inactivating the AKT signaling pathway
AU  - Dingmei Deng
AU  - Xian Ye
AU  - Xiyue Wang
AU  - Guangning He
PY  - 2019
JO  - RSC Advances
DO  - 10.1039/c9ra00016j
UR  - https://doi.org/10.1039/c9ra00016j
ER  -

APA

Deng, D., Ye, X., Wang, X., & He, G. (2019). Retracted Article: Gemcitabine aggravates miR-199a-5p-mediated breast cancer cell apoptosis by promoting VEGFA downregulation <i>via</i> inactivating the AKT signaling pathway. RSC Advances. https://doi.org/10.1039/c9ra00016j

Source records

crossref · retrieved 2026-09-25T06:34:20.913Z